Form 4: Vaxcyte SVP Sells Shares, Gifts to Charity

Vaxcyte's SVP of Finance, Elvia Cowan, reported sales of common stock totaling 11,623 shares and a gift of 1,000 shares to a charitable fund.

Summary

• Elvia Cowan, Senior Vice President of Finance at Vaxcyte, Inc., reported transactions involving the company's common stock.
• On December 23, 2025, Cowan sold 4,907 shares of common stock at a price of $47.899 per share.
• On the same date, an additional 6,716 shares of common stock were sold at $47.935 per share.
• Also on December 23, 2025, 1,000 shares of common stock were gifted to a Charitable Donor Advised Fund.
• These transactions were made pursuant to a Rule 10b5-1(c) plan.
• Following these reported transactions, Cowan directly beneficially owns 13,534 shares of Vaxcyte common stock.
• The reported beneficial ownership includes one share acquired on November 17, 2025, under the Issuer's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction report (Form 4) detailing sales and a gift of shares, likely pre-planned under a 10b5-1 plan. It does not inherently indicate positive or negative sentiment about the company's performance or future prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding insider trading activity, which can be interpreted as routine diversification or part of a pre-arranged plan.
• Charitable Donor Advised Fund: Received 1,000 shares of Vaxcyte common stock as a gift.

Key Dates

Recommendation

This Form 4 filing reports routine insider transactions, including sales and a charitable gift, likely executed under a pre-arranged 10b5-1 plan. Such transactions typically do not provide new fundamental information about the company's operational performance or future prospects that would warrant a change in investment recommendation. Investors should 'hold' their position and look to other filings (e.g., 10-K, 10-Q) for more substantive financial and strategic updates.

Keywords

Vaxcyte, PCVX, Insider Trading, Stock Sale, Form 4, Elvia Cowan, SVP Finance, Common Stock, Charitable Gift, 10b5-1 Plan